The impact of chronic obstructive pulmonary disease (COPD) and its associated lung hyperinflation on cardiac structure and function by unknown
POSTER PRESENTATION Open Access
The impact of chronic obstructive pulmonary
disease (COPD) and its associated lung
hyperinflation on cardiac structure and function
Ian S Stone1,2*, Mohammed Y Khanji1, Wai-Yee James1,2, Armida Balawon1, Redha Boubertakh1, Neil C Barnes2,3,
Steffen E Petersen1
From 18th Annual SCMR Scientific Sessions
Nice, France. 4-7 February 2015
Background
Significant cardiovascular morbidity and mortality exists in
COPD, independent of traditional risk factors, although
the mechanisms are poorly understood. Lung hyperinfla-
tion, the presence of supra-normal residual volumes
(RVol) at the end of expiration, is one postulated mechan-
ism. We sought to investigate the impact of COPD on car-
diac structure and function compared to a control group
with equivalent cardiovascular risk and look at the relative
contributions of lung hyperinflation, defined as RVol per
cent predicted value >120 %, as well as traditional spiro-
metric measures.
Methods
45 consecutive COPD patients with lung hyperinflation
randomised to the DEFLATA study underwent cardiac
magnetic resonance at 1.5 T, spirometric and body
plethysmographic assessment at baseline. 9 were excluded
from this analysis due to a history of known cardiovascu-
lar disease and/or atrial fibrillation and the remaining 36
were compared to 44 consecutive patients with increased
cardiovascular risk and normal spirometry who under-
went CMR as part of the HAPPY London Study.
Results
There was no difference in age, gender, renal function or
cardiovascular risk (QRisk) scores between the groups.
Decreased Right ventricular (RV) and Left ventricular (LV)
indexed end diastolic volumes (EDVI) were found in the
COPD group (RVEDVI 77±18 vs 88±19 ml p=0.009;
LVEDVI 63±14 vs 77±15 ml p<0.0001) with decreased but
preserved LV systolic function (LV Ejection fraction (EF)
60±7 vs 64±7 % p=0.005). RVEF was increased (63±7 vs
55±7 ml P<0.0001) as a consequence of preserved stroke
volume (RVSVI 48±12 vs 47±9 ml, p=0.71). In the COPD
group a 10% increase in RVol per cent predicted resulted
in a 1.97 ml, 1.66 ml and 1.36 ml reduction in RVEDVI,
LVEDVI and Left Atrial (LA) ESVI respectively (RVEDVI
b=-0.197, p=0.017; LVEDVI b=-0.166, p=0.018; LAESVI
b=-0.136, p=0.008) independent of age, sex, oxygen satura-
tions, and Qrisk score. Furthermore a relationship
between Rvol and LAEF (b=-0.197, p=0.024) was found
although not between LVEF or RVEF. Similar relation-
ships were found for the expiratory flow limitation mea-
sure per cent-predicted Forced expiratory volume in 1
second (FEV1), although no relationship was found with
regard to airflow obstruction (FEV1/Forced vital capacity).
Conclusions
Morphological and functional differences exist between
hyperinflated COPD patients and a control group with
equivalent cardiac risk as defined by traditional risk fac-
tors. RVol and FEV1 per cent-predicted appear to be
independently associated with cardiac chamber size.
Effects are also seen on atrial function although right
ventricular adaptation has ensured systolic function is
preserved. Further studies are warranted to establish to
what extent lung hyperinflation impacts on diastolic
function and whether these changes are reversible.
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